ArticleMediterranean journal of rheumatology2026
Pan-Immune-Inflammation Value Predicts Disease Activity and Ocular Involvement in Behçet's Disease: A Case-Control Study.
Article in Mediterranean journal of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective/Aim: Behçet's disease (BD) lacks distinctive laboratory findings, so this study aimed at evaluating the pan-immune-inflammation value (PIV), neutrophil to lymphocyte ratio (NLR), platelets to lymphocytes ratio (PLR), and monocytes to lymphocytes ratio (MLR) in BD in addition to investigating their relationship with disease activity. Methods: This case control study included 40 BD patients and 40 age and sex matched healthy volunteers. Complete clinical evaluation and disease activity scoring were conducted. Complete blood count was done for all participants with calculation of PIV, NLR, PLR and MLR. Results: BD patients showed significantly higher PIV, NLR, PLR and MLR level than healthy participants (p=0.04, 0.04, < 0.001 and 0.007, respectively). PIV showed significant positive correlation with BDCAF and erythrocyte sedimentation rate (p= 0.025 and 0.039, respectively). We detected a significantly greater PIV in patients with active ocular and musculoskeletal disease (p=0.001 and 0.037 respectively). At a cutoff of 238.26, PIV yielded an AUC of 0.81 (95% CI, p=0.001), with 83% sensitivity and 82% specificity for detecting active ocular involvement. Conclusion: PIV showed positive correlation with disease activity. PIV is superior to other studied blood cells derived ratios in detecting active ocular involvement in BD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.